⌘K
Loading ticker…
As of 2026-08-21, TELA Bio, Inc. Common Stock (TELA) has a 3-month relative strength percentile of 13 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 37. The current market Stance is 49.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 13.1%, relative volume 0.35×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
TELA is in a stage 4 downtrend, week 2. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -15.3% / -27.1%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
TELA is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $713K notional.
Held by 3 ETFs · $1M across latest filings · largest weight 0.01% (IWC).
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $713K | — |
| VXFVanguard Extended Market ETF | 0.00% | $242K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TELA Jan avg: -5.69% median: -5.94% win: 50% σ: 9.68% n: 4 2022-04-12 → 2026-07-31 | TELA Feb avg: -7.84% median: -8.00% win: 0% σ: 4.55% n: 4 2022-04-12 → 2026-07-31 | TELA Mar avg: -23.54% median: -22.35% win: 25% σ: 21.46% n: 4 2022-04-12 → 2026-07-31 | TELA Apr avg: -5.16% median: -14.18% win: 20% σ: 26.15% n: 5 2022-04-12 → 2026-07-31 | TELA May avg: 12.04% median: 10.88% win: 80% σ: 24.74% n: 5 2022-04-12 → 2026-07-31 | TELA Jun avg: 0.43% median: 0.00% win: 60% σ: 24.00% n: 5 2022-04-12 → 2026-07-31 | TELA Jul avg: -1.72% median: -3.36% win: 20% σ: 10.17% n: 5 2022-04-12 → 2026-07-31 | TELA Aug avg: -6.78% median: 1.50% win: 50% σ: 18.90% n: 4 2022-04-12 → 2026-07-31 (current) | TELA Sep avg: -11.26% median: -14.52% win: 25% σ: 8.52% n: 4 2022-04-12 → 2026-07-31 | TELA Oct avg: -7.17% median: -6.38% win: 50% σ: 18.00% n: 4 2022-04-12 → 2026-07-31 | TELA Nov avg: -2.87% median: -6.22% win: 25% σ: 9.98% n: 4 2022-04-12 → 2026-07-31 | TELA Dec avg: 15.73% median: 14.84% win: 75% σ: 19.48% n: 4 2022-04-12 → 2026-07-31 |